China · Investor

6 Dimensions Capital

Last cheque observed Feb 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietNew fund, Dec 2017VC firm

SeedSeries ASeries BHealthcareLife Sciences

Cheques on record
0%of best year0cheques in 12 months, 16 on record
Since the last cheque2809days00hrs00min00sec
Median round$71MRounds led0 of 16Mostly inUnited States, 75%
Pitch 6 Dimensions Capital

6 Dimensions Capital highlights

  1. 01

    16 rounds on record

  2. 02

    Mostly Series B and Series A: 87% of its rounds

What they do

6 Dimensions Capital is a leading global healthcare investment firm with offices in Boston, San Francisco, Hong Kong and Shanghai. The firm focuses on the investments of healthcare startups or growth stage companies.From their own website
Type
VC firm
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
HealthcareLife Sciences
Based in
HONG KONG, China
Cold pitches
Accepted

The record

Every round we can evidence, newest first16 appearances

  1. 2019

    3 rounds

  2. Feb
    NeusperaSeries B · US · FinSMEs$26MWith 4 others
  3. Feb
    HiberCellSeries A · US · FinSMEs$61MWith 3 others
  4. Jan
    Dewpoint TherapeuticsSeries A · US · FinSMEs$60MWith 4 others
  5. 2018

    9 rounds

  6. Nov
    Kymera TherapeuticsSeries B · US · FinSMEs$65MWith 7 others
  7. Sept
    Fulcrum TherapeuticsSeries B · US · FinSMEs$80MWith 6 others
  8. Jun
    iTeosSeries B · BE · Biospace$75MWith 5 others
  9. May
    Brii BioCN · FinSMEs$260MWith 5 others
  10. May
    CStoneSeries B · CN · FinSMEs$260MWith 13 others
  11. Mar
    TCR2Series B · US · FinSMEs$125MWith 9 others
  12. Mar
    UnitySeries C · US · FinSMEs$55MWith 11 others
  13. Mar
    IdeayaSeries B · US · FinSMEs$94MWith 12 others
  14. Feb
    Viela BioSeries A · US · FinSMEs$250MWith 4 others
  15. 2017

    4 rounds

  16. Nov
    Semma TherapeuticsSeries B · US · FinSMEs$114MWith 10 others
  17. Nov
    Medeor TherapeuticsSeries B · US · FinSMEs$57MWith 3 others
  18. Nov
    AnchorDXSeries B · CN · China Money Network$28MWith 4 others
  19. Jan
    CentrexionSeries D · US · FinSMEs$67MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration8 named

CZChing ZhuManager of General PartneriFiling they signed
EHEdward HuManager of General PartneriFiling they signed
GLGe LiManager of General PartneriFiling they signed
LCLeon ChenManager of General PartneriFiling they signed
LCLianyong ChenDirector & MemberiForm ADV
QZQingsheng ZhuDirector & MemberiForm ADV
SYSau Yin ChungDirector & MemberiForm ADV
WLWei LiManager of General PartneriFiling they signed

We also hold 27 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$303Mgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
Legal name
6 Dimensions Capital Limited
SEC number
CRD 292273

Who they invest alongside

The investors most often in the same rounds as 6 Dimensions Capital. A count of rooms they were both in, not a relationship either has claimed.

Alexandria Real Estate EquitiesVC firm3rounds togetherArchHedge fund3rounds togetherBoyu CapitalPrivate equity3rounds togetherHill House CapitalFamily office3rounds togetherArrowMark PartnersPrivate equity2rounds togetherCelgeneGrowth equity2rounds togetherEcoR1 CapitalPrivate equity2rounds togetherSanofi VenturesCorporate VC2rounds togetherSirona CapitalVC firm2rounds togetherWuXi HealthcareGrowth equity2rounds togetherYunFeng CapitalPrivate equity2rounds together

Recently backed

The latest companies 6 Dimensions Capital put money into.

HiberCell$61M · Feb 2019Dewpoint Therapeutics$60M · Jan 2019Kymera Therapeutics$65M · Nov 2018Fulcrum Therapeutics$80M · Sept 2018AnchorDX$28M · Nov 2017

Quick answers about 6 Dimensions Capital

What does 6 Dimensions Capital invest in?

6 Dimensions Capital invests most often at Series B and Series A (87% of the rounds on record), in sectors such as Healthcare and Life Sciences.

How active is 6 Dimensions Capital?

16 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2019.

What has 6 Dimensions Capital invested in recently?

Its most recent investments on record: Neuspera (Series B, Feb 2019), HiberCell (Series A, Feb 2019) and Dewpoint Therapeutics (Series A, Jan 2019).

How big are 6 Dimensions Capital's cheques?

The median round it joins is $71M.

Does 6 Dimensions Capital lead rounds?

Rarely, if at all: none of its 16 investments on record names it as the lead.

Where does 6 Dimensions Capital invest?

Most of the companies it backs are in the United States (75%), China (19%) and Belgium (6%).

Is 6 Dimensions Capital investing now?

No investments in the last 12 months; the latest was in Feb 2019.

Who does 6 Dimensions Capital invest alongside?

Most often Alexandria Real Estate Equities (3 rounds together), Arch (3 rounds together) and Boyu Capital (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it